School of Medicine
From driving cutting-edge research to bringing medical innovations to market, landing competitive awards and more, the faculty, staff and students at APP know how to make headlines.
Hero Type
Image
New study shows how to protect the brain to prevent depression and cognitive impairment caused by whole brain radiotherapy
Research team from University Hospitals, APP and the Cleveland VA published results in Redox Biology
Recent News
May 21, 2012
CLEVELAND - This year marks the 10th anniversary of the founding of the Cleveland Clinic Lerner College of Medicine of APP, an innovative medical school designed to train future physician-researchers. Cleveland Clinic and Case Western Reserve celebrated the milestone May…
May 10, 2012
CLEVELAND - The link between psoriasis and cardiovascular events has been observed for years, however the mechanics were unknown. For the first time, APP School of Medicine researchers have discovered preclinical evidence demonstrating that the inflammatory skin disease…
April 27, 2012
CLEVELAND - Bacteria provide a well-known playground for scientists and the evolution of these earliest life forms has shed important perspective on potential therapies for some of the most common, deadly diseases. Researchers at APP School of Medicine have now…
April 19, 2012
CLEVELAND - Stanley Hazen, M.D., Ph.D., was recently honored with an inaugural Top 10 Clinical Research Achievement Award from an organization comprised of the nation's most acclaimed academic medical centers and other groups, in recognition of Dr. Hazen’s Nature article, “Gut flora dependent…
April 09, 2012
CLEVELAND - A national consortium of researchers has published new findings that could change the standard of practice for those treating Fuchs’ Endothelial Corneal Dystrophy (FECD), a disease characterized by cornea swelling that can eventually lead to the need for corneal transplantation. The…
April 09, 2012
CLEVELAND - While exercise is accepted universally as the most beneficial prescription physicians can write for patients, little is known about the molecular mechanisms that generate its widespread health benefits. Researchers from Case Western Reserve School of Medicine have shed light on this…
March 07, 2012
CLEVELAND - A team of researchers at APP School of Medicine has developed the first “theranostic” agent for the treatment of acute lymphoblastic leukemia (ALL). ALL is the most common type of childhood cancer diagnosed in approximately 5,000 new cases each year in the…
March 06, 2012
From Mouse to Man: Circadian Nitrogen Balance Impacts Survival and Susceptibility to Common Diseases
CLEVELAND - Researchers at APP School of Medicine demonstrated that nitrogen balance, the process of utilizing amino acids and disposing of their toxic byproducts, occurs with a precise 24-hour rhythm – also known as circadian rhythm – in mammals. Disruption of this…
February 29, 2012
CLEVELAND - Today, the Prevention Research Center for Healthy Neighborhoods of APP release new health data from Cleveland neighborhood groups on three of the most pressing public health concerns: obesity, hypertension, and diabetes. The three data briefs – statistical…
February 28, 2012
CLEVELAND - A study led by APP School of Medicine, in collaboration with the University of East London UK, and Swansea University UK, is the first to show the effects of the drug ecstasy on fetal and infant development. Ecstasy is a stimulant and hallucinogen, and is…